Resmed (RSMDF) Curent Deferred Tax Liability (2010 - 2015)
Resmed's (RSMDF) quarterly Curent Deferred Tax Liability came in at $815000.0 in Q4 2015, up 30.4% on a YoY basis from $625000.0 in Q4 2014, and up 5.03% quarter-over-quarter from $776000.0 in Q3 2015.
Analysis
Resmed (RSMDF) Curent Deferred Tax Liability (2010 - 2015) Analysis & Trends
Resmed (RSMDF) has reported Curent Deferred Tax Liability for 6 consecutive years, with $815000.0 the latest figure, recorded in Q4 2015.
- For the quarter ending Q4 2015, Curent Deferred Tax Liability rose 30.4% year-over-year to $815000.0; the trailing twelve-month figure through Dec 2015 stood at $815000.0 (up 30.4% YoY), and the FY2015 full-year result was $796000.0, up 11.02% from the prior year.
- Curent Deferred Tax Liability grew to $815000.0 in Q4 2015 per RSMDF's latest filing, from $776000.0 in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $1.1 million in Q2 2012 and bottomed at $497000.0 in Q1 2011.
- Historically, Curent Deferred Tax Liability has averaged $697100.0 across 5 years, with a median of $655500.0 in 2012.
- The sharpest annual moves came in 2012 and 2013: Curent Deferred Tax Liability soared 67.66% in 2012, then plunged 41.57% in 2013.
- Over 5 years, Curent Deferred Tax Liability stood at $574000.0 in 2011, then surged by 36.59% to $784000.0 in 2012, then declined by 5.48% to $741000.0 in 2013, then dropped by 15.65% to $625000.0 in 2014, then jumped by 30.4% to $815000.0 in 2015.
- According to Business Quant data, Curent Deferred Tax Liability over the past three periods registered $815000.0, $776000.0, and $796000.0 for Q4 2015, Q3 2015, and Q2 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | - |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 815,000.00 |
| Sep 30, 2015 | 776,000.00 |
| Jun 30, 2015 | 796,000.00 |
| Mar 31, 2015 | 639,000.00 |
| Dec 31, 2014 | 625,000.00 |
| Sep 30, 2014 | 651,000.00 |
| Jun 30, 2014 | 717,000.00 |
| Mar 31, 2014 | 774,000.00 |
| Dec 31, 2013 | 741,000.00 |
| Sep 30, 2013 | 731,000.00 |
| Jun 30, 2013 | 627,000.00 |
| Mar 31, 2013 | 632,000.00 |
| Dec 31, 2012 | 784,000.00 |
| Sep 30, 2012 | 660,000.00 |
| Jun 30, 2012 | 1.07 Mn |
| Mar 31, 2012 | 597,000.00 |
| Dec 31, 2011 | 574,000.00 |
| Sep 30, 2011 | 593,000.00 |
| Jun 30, 2011 | 640,000.00 |
| Mar 31, 2011 | 497,000.00 |